LOXL2 and cancer: Indeed, cells derived from the secondary mammospheres of MCF-7-LOXL2#12 cells (enriched for cancer stem cell-like cells) could differentiate to heterogeneous cellular clusters in the 3D BME system with heterogeneous expression (positive and negative expression) of the luminal marker CK8/18 (Figure 5E).